Clinical evaluation of two daily doses of naproxen and indomethacin: result of a double-blind crossover trail.
Curr Med Res Opin
; 3(6): 359-66, 1975.
Article
en En
| MEDLINE
| ID: mdl-1102259
ABSTRACT
A double-blind crossover clinical trial is reported on the effects of naproxen in two doses, 500 mg. and 750 mg. daily, and 100 mg. indomethacin daily in 23 patients with classical rheumatoid arthritis, each drug being given for 1 week. The results show that there was little to choose between the drugs and that there was clinical equivalence between the two doses of naproxen. Radioactive pertechnetate (99mTc) joint uptakes were depressed by both naproxen and indomethacin, indicating anti-inflammatory effect.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Artritis Reumatoide
/
Indometacina
/
Naproxeno
/
Ácidos Naftalenoacéticos
Tipo de estudio:
Clinical_trials
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
1975
Tipo del documento:
Article